Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:e9034
doi: 10.1161/01.CIR.0000038081.34105.79
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fox, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, R.

(Circulation. 2002;106:e9034.)
© 2002 American Heart Association, Inc.

Cardiovascular News

Robin Fox, FRCP

Circulation Newswriter


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Cell Transplants for Ischemic Myocardium

Just a few years ago, the adult myocardium was thought to be incapable of regeneration. However, the rate of cell loss has proved to be such that, without cell replacement, most people would be heartless by the age of 40. To discover where the new cells come from, several groups have looked at sex-mismatched heart transplants. The presence of Y-chromosomes in the myocardium of a female heart transplanted into a man might suggest that certain cells originate outside the heart. One objection to some of the studies is that they do not allow for the microchimerism that can arise in a woman who has been pregnant with a male fetus. At the Berlin meeting, this objection was met in a biopsy study reported by Dr A. Bayes-Genis, from the Hospital Santa Crevi, Sant Pau, Barcelona, Spain. Muscle cells with two X-chromosomes were clearly evident in male hearts transplanted into females. Dr P. Muller and co-workers, from the Department of Internal Medicine, University of the Saarlandes, Homburg, Germany, have examined these cells and confirmed that they are cardiomyocytes connected by gap junctions to adjacent myocytes (Circulation. 2002;106:31–35). In the opinion of Dr M.L. Entman, from Baylor College of Medicine, Houston, Tex, all evidence points to a low-capacity system that has evolved for slow replacement of adult cardiac cells over a lifetime. How, then, might this process be sped up to aid the repair of damaged myocardium? At the meeting there was much debate on the potential value of bone . . . [Full Text of this Article]